Provided by Tiger Trade Technology Pte. Ltd.

Advanced

267.00
-9.8600-3.56%
Volume:423.71K
Turnover:113.81M
Market Cap:10.68B
PE:49.53
High:278.00
Open:272.00
Low:265.89
Close:276.86
52wk High:397.44
52wk Low:144.09
Shares:40.01M
Float Shares:38.77M
Volume Ratio:0.79
T/O Rate:1.09%
Dividend:0.40
Dividend Rate:0.15%
EPS(TTM):5.39
EPS(LYR):3.85
ROE:16.27%
ROA:6.25%
PB:7.34
PE(LYR):69.41

Loading ...

Trump Administration in Advanced Talks for Stake in Venezuelan Oil Fields

Dow Jones
·
Aug 28

HUTCHMED Wins China NMPA Nod for ATLED in Advanced Liver Cancer

TIPRANKS
·
Aug 28

Advanced Energy EVP, General Counsel Vonne Elizabeth Karpinski Sells 907 Shares Worth $263,575.35

Reuters
·
Aug 28

Solstice Advanced Materials Terminates Element Solutions Merger

MT Newswires Live
·
Aug 28

Solstice Advanced Materials announces $500M share repurchase program

TIPRANKS
·
Aug 28

Press Release: Element Solutions Announces Mutual Termination of Merger Agreement with Solstice Advanced Materials

Dow Jones
·
Aug 28

How Investors Are Reacting To Amkor Technology (AMKR) AI-Fueled Earnings And Advanced Packaging Expansion

Simply Wall St.
·
Aug 27

ImmuneOnco Starts Phase II Trial of Dual-Immunotherapy Combo for Advanced Liver Cancer

TIPRANKS
·
Aug 27

Fosun Pharma Unit Secures Exclusive Rights to Advanced Bispecific Antibody Drug

TIPRANKS
·
Aug 27

The Bull Case For Uniti Group (UNIT) Could Change Following Elevation To Cato Advanced Partner Tier

Simply Wall St.
·
Aug 27

Morgan Stanley Keeps Their Buy Rating on CNGR Advanced Material Co., Ltd. Class H (2579)

TIPRANKS
·
Aug 27

Lam Research Marks Construction of New Oregon Lab for Advanced AI Chip Development

MT Newswires Live
·
Aug 27

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

GlobeNewswire
·
Aug 26

Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc

GlobeNewswire
·
Aug 26

Advanced Info Service Forms New Subsidiary

MT Newswires Live
·
Aug 26

Morgan Advanced Materials Signals Steady Progress Amid Headwinds

TIPRANKS
·
Aug 26

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

GlobeNewswire
·
Aug 25

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlobeNewswire
·
Aug 25

CNGR Advanced Material Directors Approve Budget Increase for Daily Related-Party Transactions with Two Entities

MT Newswires Live
·
Aug 25

CNGR Advanced Material Revises Interim Dividend and Sets Cross-Border Tax Terms

TIPRANKS
·
Aug 25